Johns Hopkins University
Locations
Transplant Summary
Overview
Johns Hopkins is a core center of the BMT clinical trials network; COG approved. Current studies are looking at ways to facilitate graft tolerance to reduce the risk of GVHD and reduce graft rejection in patients with mismatched donors, as well as investigating safer ways to transplant non-malignant diseases. Some patients with fully matched donors do not require immune suppression beyond four days after transplantation.This center has been performing allogeneic transplants since 1969 and has been an NMDP transplant center since October 1997.
Attending physicians
Adult - Syed Abbas Ali, Richard Ambinder, Javier Bolanos-Meade, Robert Brodsky, Amy Dezern, Ephraim Fuchs, Ivana Gojo, Carol Ann Huff, Tania Jain, Richard Jones, Mark Levis, Leo Luznik, B. Douglas Smith, Lode Swinnen, Nina Wagner-Johnston
Pediatric - Allen R. Chen, Kenneth Cohen, Kenneth Cooke, Alan Friedman, Christopher Gamper, Nico Llosa, Margaret Showel, Donald Small, Heather Symons, Elias ZambidisTransplants performed
Marrow/PBSC, single cord, and double cordCord blood transplants
Adult and pediatricPatient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 612 patients.The actual 1-year survival of these patients is 79.7%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 76.2% and 82.4%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
562
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow127PBSC158Cord blood0Total285Unrelated donorMarrow1PBSC112Cord blood0Total113Total allogeneicMarrow128PBSC270Cord blood0Total398AutologousMarrowBoth marrow & PBSC 164PBSC—Cord blood—Total164Total combinedMarrowBoth marrow & PBSC 562PBSC—Cord blood0Total562Total pediatric transplants
58
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow30PBSC6Cord blood0Total36Unrelated donorMarrow1PBSC3Cord blood0Total4Total allogeneicMarrow31PBSC9Cord blood0Total40AutologousMarrowBoth marrow & PBSC 18PBSC—Cord blood—Total18Total combinedMarrowBoth marrow & PBSC 58PBSC—Cord blood0Total58All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-183719-447445-6412565+85Total321Unrelated 0-18619-444045-644765+25Total118Autologous 0-182019-442045-648665+56Total182Total 0-186319-4413445-6425865+166Total621Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
If you have questions about costs and financial services at this center, please call the transplant center’s direct phone number.NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
No survivorship program information is available. Contact the center for information about post-transplant care.